Trial Outcomes & Findings for Neurobehavioral Mechanisms of Cocaine Choice (NCT NCT04296006)

NCT ID: NCT04296006

Last Updated: 2025-04-03

Results Overview

The reinforcing effects of cocaine are determined using a reinforcement learning choice task. Subjects complete trials in which they could possibly receive the available cocaine dose or money. Reinforcing effects are measured for a fixed cocaine dose when three amounts of money are available as alternatives to cocaine. Each money value is tested in a separate session.

Recruitment status

COMPLETED

Study phase

EARLY_PHASE1

Target enrollment

15 participants

Primary outcome timeframe

Choices occur across a 40 minute session

Results posted on

2025-04-03

Participant Flow

3 subjects were lost to follow up and 4 subjects were screen fails. All 8 subjects who were admitted to the inpatient unit completed the three within-subjects experimental conditions.

Participant milestones

Participant milestones
Measure
The Impact of Alternative Reinforcer Magnitude on Cocaine vs Money Choice
Subjects complete 200 trials on a probabilistic concurrent choice procedure in which 3 mg/70 kg intravenous cocaine and varying amounts of money ($0.25, 1.00, 4.00) are available during each trial. Money: Three money values offered as alternatives to cocaine. Cocaine HCl: 3 mg/70 kg is available as an alternative to money.
Overall Study
STARTED
8
Overall Study
COMPLETED
8
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Neurobehavioral Mechanisms of Cocaine Choice

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
The Effects of Alternative Reinforcer Magnitude on Cocaine vs Money Choice
n=8 Participants
Subjects complete 200 trials on a probabilistic concurrent choice procedure in which 3 mg/70 kg intravenous cocaine and varying amounts of money ($0.25, 1.00, 4.00) are available during each trial. Money: Three money values offered as alternatives to cocaine. Cocaine HCl: 3 mg/70 kg is available as an alternative to money.
Age, Continuous
49 years
n=5 Participants
Sex: Female, Male
Female
1 Participants
n=5 Participants
Sex: Female, Male
Male
7 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
7 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
3 Participants
n=5 Participants
Race (NIH/OMB)
White
4 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
1 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Region of Enrollment
United States
8 participants
n=5 Participants

PRIMARY outcome

Timeframe: Choices occur across a 40 minute session

Population: People with cocaine use disorder

The reinforcing effects of cocaine are determined using a reinforcement learning choice task. Subjects complete trials in which they could possibly receive the available cocaine dose or money. Reinforcing effects are measured for a fixed cocaine dose when three amounts of money are available as alternatives to cocaine. Each money value is tested in a separate session.

Outcome measures

Outcome measures
Measure
$0.25 Alternative Reinforcer Value
n=8 Participants
Subjects complete 200 trials on a probabilistic concurrent choice procedure in which 3 mg/70 kg intravenous cocaine and $0.25 are available during each trial. Money: Three money values offered as alternatives to cocaine. Cocaine HCl: 3 mg/70 kg is available as an alternative to money.
$1.00 Alternative Reinforcer Value
n=8 Participants
Subjects complete 200 trials on a probabilistic concurrent choice procedure in which 3 mg/70 kg intravenous cocaine and $1.00 are available during each trial. Money: Three money values offered as alternatives to cocaine. Cocaine HCl: 3 mg/70 kg is available as an alternative to money.
$4.00 Alternative Reinforcer Value
n=8 Participants
Subjects complete 200 trials on a probabilistic concurrent choice procedure in which 3 mg/70 kg intravenous cocaine and $4.00 are available during each trial. Money: Three money values offered as alternatives to cocaine. Cocaine HCl: 3 mg/70 kg is available as an alternative to money.
The Number of Times Cocaine Was Selected in the Presence of a Monetary Reward Alternative
110 number of choices
Standard Deviation 34
98 number of choices
Standard Deviation 17
90 number of choices
Standard Deviation 12

Adverse Events

$0.25 Alternative Reinforcer Value

Serious events: 0 serious events
Other events: 3 other events
Deaths: 0 deaths

$1.00 Alternative Reinforcer Value

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

$4.00 Alternative Reinforcer Value

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
$0.25 Alternative Reinforcer Value
n=8 participants at risk
Subjects complete 200 trials on a probabilistic concurrent choice procedure in which 3 mg/70 kg intravenous cocaine and $0.25 are available during each trial. Money: Three money values offered as alternatives to cocaine. Cocaine HCl: 3 mg/70 kg is available as an alternative to money. This is a within-subjects study, but AE results are reported by each of the three experimental conditions (i.e., 3 separate alternative money conditions) that each subject completed on separate sessions.
$1.00 Alternative Reinforcer Value
n=8 participants at risk
Subjects complete 200 trials on a probabilistic concurrent choice procedure in which 3 mg/70 kg intravenous cocaine and $1.00 are available during each trial. Money: Three money values offered as alternatives to cocaine. Cocaine HCl: 3 mg/70 kg is available as an alternative to money. This is a within-subjects study, but AE results are reported by each of the three experimental conditions (i.e., 3 separate alternative money conditions) that each subject completed on separate sessions.
$4.00 Alternative Reinforcer Value
n=8 participants at risk
Subjects complete 200 trials on a probabilistic concurrent choice procedure in which 3 mg/70 kg intravenous cocaine and $4.00 are available during each trial. Money: Three money values offered as alternatives to cocaine. Cocaine HCl: 3 mg/70 kg is available as an alternative to money. This is a within-subjects study, but AE results are reported by each of the three experimental conditions (i.e., 3 separate alternative money conditions) that each subject completed on separate sessions.
Cardiac disorders
Elevated Heart Rate
12.5%
1/8 • Number of events 1 • AEs were collected during the duration of data collection on three separate days.
0.00%
0/8 • AEs were collected during the duration of data collection on three separate days.
0.00%
0/8 • AEs were collected during the duration of data collection on three separate days.
Cardiac disorders
Elevated Blood Pressure
12.5%
1/8 • Number of events 1 • AEs were collected during the duration of data collection on three separate days.
0.00%
0/8 • AEs were collected during the duration of data collection on three separate days.
0.00%
0/8 • AEs were collected during the duration of data collection on three separate days.
Nervous system disorders
Headache
12.5%
1/8 • Number of events 1 • AEs were collected during the duration of data collection on three separate days.
12.5%
1/8 • Number of events 1 • AEs were collected during the duration of data collection on three separate days.
12.5%
1/8 • Number of events 1 • AEs were collected during the duration of data collection on three separate days.

Additional Information

Joshua Lile, Ph.D.

University of Kentucky

Phone: 859-323-6034

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place